Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Viatris (Nasdaq: VTRS) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026. The company's presentation and fireside chat begin at 9:00 a.m. PT / 12:00 p.m. ET. A live webcast will stream at investor.viatris.com, and an archived recording will be available at the same location for a limited time after the event.
Positive
- None.
Negative
- None.
News Market Reaction – VTRS
In the Dec 17 session, VTRS gained 2.09%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 24 | Investor conferences | Neutral | +1.1% | Scheduled fireside chats at two early-December healthcare investor conferences. |
| Nov 13 | Workplace recognition | Positive | -0.9% | Named to Fortune World’s Best Workplaces 2025 list highlighting culture and inclusion. |
| Nov 06 | Earnings and guidance | Neutral | -6.0% | Reported Q3 2025 results with flat revenue, lower EPS, and raised guidance ranges. |
| Nov 04 | Dividend declaration | Positive | -0.4% | Board declared a $0.12 per-share quarterly dividend with December 2025 payment date. |
| Oct 28 | R&D collaboration | Positive | -1.3% | Collaboration with Locus Biosciences on phage therapies for ophthalmic infections. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows several instances where positive or shareholder-friendly news (awards, dividends, collaborations) coincided with modest negative next-day price reactions, suggesting a tendency for the stock to fade good headlines.
Over the last few months, Viatris has focused on investor visibility and capital return alongside operational updates. It announced participation in multiple investor conferences in early December 2025, received recognition as one of the Fortune World’s Best Workplaces in 2025, and reported Q3 2025 results with updated guidance. The company also declared a $0.12 quarterly dividend on November 3, 2025 and entered a bacteriophage collaboration in ophthalmology. Today’s conference appearance fits this pattern of ongoing investor outreach and strategic communications.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the event can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302643963.html
SOURCE Viatris Inc.